1. Home
  2. ENSC vs NUWE Comparison

ENSC vs NUWE Comparison

Compare ENSC & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • NUWE
  • Stock Information
  • Founded
  • ENSC 2003
  • NUWE 1999
  • Country
  • ENSC United States
  • NUWE United States
  • Employees
  • ENSC N/A
  • NUWE N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ENSC Health Care
  • NUWE Health Care
  • Exchange
  • ENSC Nasdaq
  • NUWE Nasdaq
  • Market Cap
  • ENSC 5.5M
  • NUWE 5.2M
  • IPO Year
  • ENSC N/A
  • NUWE N/A
  • Fundamental
  • Price
  • ENSC $2.64
  • NUWE $1.00
  • Analyst Decision
  • ENSC
  • NUWE Strong Buy
  • Analyst Count
  • ENSC 0
  • NUWE 1
  • Target Price
  • ENSC N/A
  • NUWE $17.00
  • AVG Volume (30 Days)
  • ENSC 24.9K
  • NUWE 83.4K
  • Earning Date
  • ENSC 05-12-2025
  • NUWE 05-06-2025
  • Dividend Yield
  • ENSC N/A
  • NUWE N/A
  • EPS Growth
  • ENSC N/A
  • NUWE N/A
  • EPS
  • ENSC N/A
  • NUWE N/A
  • Revenue
  • ENSC $5,210,031.00
  • NUWE $8,740,000.00
  • Revenue This Year
  • ENSC N/A
  • NUWE $22.96
  • Revenue Next Year
  • ENSC N/A
  • NUWE $29.97
  • P/E Ratio
  • ENSC N/A
  • NUWE N/A
  • Revenue Growth
  • ENSC 133.58
  • NUWE N/A
  • 52 Week Low
  • ENSC $2.12
  • NUWE $0.90
  • 52 Week High
  • ENSC $14.67
  • NUWE $14.35
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 23.45
  • NUWE 37.50
  • Support Level
  • ENSC $3.30
  • NUWE $0.91
  • Resistance Level
  • ENSC $3.58
  • NUWE $1.03
  • Average True Range (ATR)
  • ENSC 0.32
  • NUWE 0.07
  • MACD
  • ENSC -0.05
  • NUWE -0.02
  • Stochastic Oscillator
  • ENSC 22.21
  • NUWE 32.26

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.

Share on Social Networks: